| New insights in mucosal vaccine development V Pavot, N Rochereau, C Genin, B Verrier, S Paul Vaccine 30 (2), 142-154, 2012 | 243 | 2012 |
| Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells N Rochereau, D Drocourt, E Perouzel, V Pavot, P Redelinghuys, ... PLoS biology 11 (9), e1001658, 2013 | 195 | 2013 |
| Traffic of poly (lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells C Primard, N Rochereau, E Luciani, C Genin, T Delair, S Paul, B Verrier Biomaterials 31 (23), 6060-6068, 2010 | 131 | 2010 |
| Encapsulation of Nod1 and Nod2 receptor ligands into poly (lactic acid) nanoparticles potentiates their immune properties V Pavot, N Rochereau, C Primard, C Genin, E Perouzel, T Lioux, S Paul, ... Journal of controlled release 167 (1), 60-67, 2013 | 107 | 2013 |
| The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells A Gutjahr, L Papagno, F Nicoli, T Kanuma, N Kuse, MP Cabral-Piccin, ... JCI insight 4 (7), 2019 | 88 | 2019 |
| Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity V Pavot, N Rochereau, J Rességuier, A Gutjahr, C Genin, G Tiraby, ... The Journal of Immunology 193 (12), 5781-5785, 2014 | 76 | 2014 |
| Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands V Pavot, N Climent, N Rochereau, F Garcia, C Genin, G Tiraby, ... Biomaterials 75, 327-339, 2016 | 54 | 2016 |
| Human secretory IgM: an elusive player in mucosal immunity E Michaud, C Mastrandrea, N Rochereau, S Paul Trends in immunology 41 (2), 141-156, 2020 | 50 | 2020 |
| Cytomegalovirus and inflammatory bowel diseases (IBD) with a special focus on the link with ulcerative colitis (UC) A Jentzer, P Veyrard, X Roblin, P Saint-Sardos, N Rochereau, S Paul, ... Microorganisms 8 (7), 1078, 2020 | 46 | 2020 |
| Vaccination against Salmonella infection: the mucosal way R Gayet, G Bioley, N Rochereau, S Paul, B Corthésy Microbiology and Molecular Biology Reviews 81 (3), 10.1128/mmbr. 00007-17, 2017 | 46 | 2017 |
| Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity N Rochereau, V Pavot, B Verrier, F Jospin, A Ensinas, C Genin, ... Journal of Allergy and Clinical Immunology 137 (1), 214-222. e2, 2016 | 41 | 2016 |
| Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells N Rochereau, V Pavot, B Verrier, A Ensinas, C Genin, B Corthésy, S Paul European journal of immunology 45 (3), 773-779, 2015 | 41 | 2015 |
| NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn’s disease N Rochereau, X Roblin, E Michaud, R Gayet, B Chanut, F Jospin, ... Nature Communications 12 (1), 261, 2021 | 38 | 2021 |
| Brief report: a high rate of β7+ gut-homing lymphocytes in HIV-infected immunological nonresponders is associated with poor CD4 T-cell recovery during suppressive HAART A Girard, D Vergnon-Miszczycha, AE Depincé-Berger, X Roblin, F Lutch, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 72 (3), 259-265, 2016 | 37 | 2016 |
| New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses A Gutjahr, L Papagno, F Vernejoul, T Lioux, F Jospin, B Chanut, ... EBioMedicine 58, 2020 | 27 | 2020 |
| Neonate intestinal immune response to CpG oligodeoxynucleotide stimulation S Lacroix-Lamandé, N Rochereau, R Mancassola, M Barrier, A Clauzon, ... PLoS One 4 (12), e8291, 2009 | 27 | 2009 |
| Metabolites and secretory immunoglobulins: Messengers and effectors of the host–microbiota intestinal equilibrium R Goguyer-Deschaumes, L Waeckel, M Killian, N Rochereau, S Paul Trends in Immunology 43 (1), 63-77, 2022 | 25 | 2022 |
| Impact of IgA isoforms on their ability to activate dendritic cells and to prime T cells R Gayet, E Michaud, F Nicoli, B Chanut, M Paul, N Rochereau, C Guillon, ... European journal of immunology 50 (9), 1295-1306, 2020 | 25 | 2020 |
| Recent progress in HIV vaccines inducing mucosal immune responses V Pavot, N Rochereau, P Lawrence, MP Girard, C Genin, B Verrier, S Paul Aids 28 (12), 1701-1718, 2014 | 19 | 2014 |
| Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases E Michaud, L Waeckel, R Gayet, R Goguyer‐Deschaumes, B Chanut, ... EMBO Molecular Medicine 14 (8), e15386, 2022 | 16 | 2022 |
Eric PerouzelInvivoGen在 invivogen.com 的电子邮件经过验证
Eric PerouzelInvivoGen在 invivogen.com 的电子邮件经过验证
Vincent Pavot, PhDSanofi在 sanofi.com 的电子邮件经过验证